FDA approves latest version of Pfizer's COVID-19 mRNA vaccine

The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies ...

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closely match contemporary circulating ...
iHeart on MSN

FDA approves Pfizer COVID-19 vaccine targeting XFG variant

The new shots, available soon, are designed to protect against the dominant strain and will be covered by insurance.

The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why

In August 2026, Pfizer and BioNTech received U.S. FDA approval for their updated COMIRNATY COVID-19 vaccine targeting the XFG ...
FiercePharma

FDA may not renew Pfizer's pediatric COVID shot authorization, prompting potential complication for child vaccinations this fall

The ability to inoculate young children against COVID-19 in the U.S. may be diminished this fall as the FDA weighs whether to renew the emergency green light for the vaccine currently cleared in the ...
GlobalData on MSN

EMA validates Pfizer and Valneva’s Lyme disease vaccine

The submission is supported by efficacy and safety data from the Phase III VALOR clinical trial.
Seeking Alpha

Pfizer begins late-stage trial for new pneumococcal shot in infants after strong Phase 2 data

Pfizer (PFE) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed its pneumococcal 20-valent ...

Pfizer halts corona vaccine shipments to Israel after country fails to pay

Pfizer has halted shipments of coronavirus vaccines to Israel in outrage over the country failing to transfer payment for the last 2.5 million doses it supplied to the country, The Jerusalem Post has ...

GOP Congressman Slams JD Vance's Silence Over CDC's $1.24 Billion Pfizer COVID Vaccine Contracts: 'Why Isn’t He Speaking Out'

Rep. Thomas Massie (R-Ky.) questioned Vice President JD Vance‘s silence after the Trump administration established billions for Pfizer Inc.‘s COVID-19 vaccine contracts for 2026 and 2027. On Sunday, ...